作为类风湿性关节炎的辅助疗法
Mona Pathak1, Ramaprabhu Vempati2, Lisa S Wieland3
1Pharmacotherapy, College of Pharmacy, University of North Texas Health Science Center, Fortworth, Texas, USA.
The Cochrane database of systematic reviews
|January 8, 2025
概括
本审查协议评估了作为类风湿性关节炎 (RA) 补充治疗的有效性和安全性. 它旨在确定是否为RA患者提供超越标准医疗护理的好处.
科学领域:
- 类风湿病学 类风湿病学
- 补充和替代医学 补充和替代医学
- 临床研究方法论 临床研究方法论
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节炎症和疼痛.
- 目前的RA治疗侧重于疾病修饰性抗风湿药物 (DMARD) 和症状控制.
- 对于改善RA患者生活质量的非药物干预措施越来越感兴趣.
研究的目的:
- 系统地评估作为类风湿性关节炎辅助疗法的疗效.
- 评估将纳入标准RA治疗方案中的安全性.
- 综合关于对 RA 疾病活动,疼痛和身体功能的影响的证据.
主要方法:
- 这项研究是柯克伦审查的协议.
- 它将涉及对相关随机对照试验的多个电子数据库的系统搜索.
- 数据提取和偏差风险评估将遵循Cochrane指南.
主要成果:
- 该部分将在审查完成后填写.
- 预期的结果包括对对RA结果的影响的定量合成.
- 将分析有关与RA中练习相关的不良事件的安全数据.
结论:
- 这一审查将提供基于证据的结论,关于在风湿性关节炎管理中的作用.
- 结果将为临床实践指南和患者决策提供信息.
- 未来的研究方向可以根据证据缺口确定.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Centrally Acting Muscle Relaxants: Therapeutic Uses
620
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
620
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114


